A real-world study to assess the economic burden and clinical outcome in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece

被引：0
|
作者：
Karachalios, G. [1 ]
Gourgioti, R. [1 ]
Alexopoulou, A. [1 ]
Kourlaba, G. [2 ]
机构：
[1] Genesis Pharma SA, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Intens Care A, Athens, Greece
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P278
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [31] Comparative Effectiveness of Teriflunomide and Dimethyl Fumarate in Patients with Relapsing-Remitting MS in the Real-World Teri-RADAR Study
    Zivadinov, Robert
    Burudpakdee, Chakkarin
    Dwyer, Michael G.
    Bergsland, Niels
    Chavin, Jeffrey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cohan, Stanley
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 28 - 28
  • [32] Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis
    Walczak, A.
    Kurkowska-Jastrzebska, I.
    Zakrzewska-Pniewska, B.
    Dorobek, M.
    Brola, W.
    Zajdel, R.
    Bartosik-Psujek, H.
    Kulakowska, A.
    Rusek, S.
    Tutaj, A.
    Glabinski, A.
    Wlodek, A.
    Kochanowski, J.
    Stepien, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 328 - 328
  • [33] Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis
    Walczak, Agata
    Kurkowska-Jastrzebska, Iwona
    Zakrzewska-Pniewska, Beata
    Dorobek, Malgorzata
    Brola, Waldemar
    Zajdel, Radoslaw
    Bartosik-Psujek, Halina
    Stasiolek, Mariusz
    Kulakowska, Alma
    Rusek, Stanislaw
    Tutaj, Andrzej
    Glabinski, Andrzej
    Wlodek, Agata
    Kochanowski, Jan
    Ciach, Agnieszka
    Siger, Malgorzata
    Kurowska, Katarzyna
    Wicha, Wojciech
    Nojszewska, Monika
    Podlecka-Pietowska, Aleksandra
    Czajka, Anna
    Kapica-Topczewska, Katarzyna
    Bielecki, Bartosz
    Maciagowska-Terela, Marzena
    Stepien, Adam
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 184
  • [34] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Yao
    Yin, Hexiang
    Zhang, Dingding
    Xu, Yan
    Peng, Bin
    Cui, Liying
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4808 - 4816
  • [35] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Y.
    Yin, H.
    Zhang, D.
    Xu, Y.
    Peng, B.
    Cui, L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 888 - 889
  • [36] Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program
    Wiendl, Heinz
    Spelman, Tim
    Butzkueven, Helmut
    Kappos, Ludwig
    Trojan, Maria
    Su, Ray
    Campbell, Nolan
    Ho, Pei-Ran
    Licata, Stephanie
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (05) : 719 - 728
  • [37] Real-world clinical outcomes in relapsing-remitting multiple sclerosis patients who switch from natalizumab to delayed-release dimethyl fumarate: a multicenter, retrospective, observational study (STRATEGY)
    Cohan, S.
    Moses, H.
    Calkwood, J.
    Tornatore, C.
    Laganke, C.
    Smoot, K. E.
    Mann, M.
    Meka, V.
    Okwuokenye, M.
    Hotermans, C.
    Meltzer, L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 262 - 262
  • [38] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    Batista, S.
    Nunes, C. C.
    Cerqueira, J. J.
    Martins Silva, Ana
    Correia de Sa, J.
    Ferreira, J.
    Mendonca, M. T.
    Pinheiro, J.
    Salgado, V.
    Correia, A. S.
    Sequeira, J.
    Costa, A.
    Sousa, L.
    NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
  • [39] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    S. Batista
    C. C. Nunes
    J. J. Cerqueira
    Ana Martins Silva
    J. Correia de Sá
    J. Ferreira
    M. T. Mendonça
    J. Pinheiro
    V. Salgado
    A. S. Correia
    J. Sequeira
    A. Costa
    L. Sousa
    Neurological Sciences, 2021, 42 : 1995 - 2003
  • [40] Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
    Barrero, Francisco
    Mallada-Frechin, Javier
    Luisa Martinez-Gines, Maria
    Eugenia Marzo, Maria
    Meca-Lallana, Virginia
    Izquierdo, Guillermo
    Ramon Ara, Jose
    Oreja-Guevare, Celia
    Meca-Lallana, Jose
    Forero, Lucia
    Sanchez-Veram, Irene
    Jose Moreno, Maria
    PLOS ONE, 2020, 15 (04):
12345